Skip to content
Hemispherx Biopharma, Inc. Logo
  • COMPANY
  • PRODUCTS
  • R & D
    • Product Candidates Overview
    • Pipeline
    • Orphan Drug Designations
  • PARTNERING
  • INVESTOR RELATIONS
    • Press Releases
    • Events & Presentations
    • Stock Information
    • SEC Filings
    • XBRL Filings
    • Stockholder Meeting
    • Corporate Governance
    • Email Alerts
    • Investor Contact
  • BLOG
  • CONTACT

Press Releases

 
Jul 01, 2002
Hemispherx Announces Annual Shareholders Meeting To Be Held August 14th, 2002

Jun 18, 2002
Abstracts cover latest developments in the Company's HIV/AIDS Clinical Trials for Salvage Therapy and Strategic Treatment Intervention (STI)

Jun 10, 2002
Hemispherx Biopharma Receives New Patent In Europe For Oral Dosed Broad-Spectrum Immune Activators

Jun 05, 2002
Hemispherx Biopharma Europe S.A. Completes Agreement With Laboratorios Del Dr. Esteve S.A.

May 16, 2002
AUDIO WEB REPLAY OF HEMISPHERX'S MAY 16, 2002 CONFERENCE CALL AVAILABLE ON COMPANY'S WEBSITE

May 15, 2002
HEMISPHERX TO HOST CONFERENCE CALL ON FIRST QUARTER RESULTS AND NEW HIV/AIDS ACTIVITY

May 15, 2002
HEMISPHERX ANNOUNCES FIRST QUARTER RESULTS REVENUE INCREASED-NET LOSS REDUCED BY 40%

May 01, 2002
PRESIDENT/OWNER OF MAJOR INTERNATIONAL OIL EXPLORATION COMPANIES JOINS HEMISPHERX BIOPHARMA BOARD OF DIRECTORS

Apr 29, 2002
Hemispherx Announces Formation of Committee to Initiate Search For Medical Director to Lead its HIV/AIDS Division

Apr 18, 2002
Hemispherx and The AIDS Community Research Initiative of America -- ACRIA -- Launch Immunotherapeutic HIV/AIDS Clinical Trials in New York City

 69   70   71   72   73     74    75   76 
 <<   <   >   >> 
Hemispherx Biopharma, Inc. Logo White

Latest News

  • CEO Roadshow Interviews Hemispherx Thomas K. Equels
  • Introducing You to the First Ampligen Quarterly Update
  • Proactive Investors USA Sits Down with Hemispherx CEO Thomas K. Equels

Privacy / Terms of Use

  • Terms Of Use
  • Investor Contact

Tweets by AIM Immuno

© Copyright | All Rights Reserved | AIM ImmunoTech Inc. | Privacy Policy | Terms of Use
FacebookTwitterYouTubeLinkedIn

Privacy
Resize Viewer - Reduce Resize Viewer - Expand Close window